top of page
![NM.jpg](https://static.wixstatic.com/media/b11210_238b8bdb104f4a6faf60d888de815233~mv2.jpg/v1/fill/w_106,h_53,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/b11210_238b8bdb104f4a6faf60d888de815233~mv2.jpg)
The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in New Mexico in 2022.
![NM.png](https://static.wixstatic.com/media/b11210_dd4e940cc9d34fe2ae6db96f8f4509c2~mv2.png/v1/fill/w_135,h_154,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/NM.png)
Economic
Output
$2.7B
Direct Jobs Supported by the Industry
2,745
Total Jobs Supported
8,579
State Total Vendor Relationships
87
State Total Vendor Spending
$18,515,283
Clinical
Trials
232
Investments at Clinical Trial Sites
$53.4M
Clinical Trial Participants
3,536
Total Economic Impact of Clinical Trial Sites
$126M
bottom of page